Clinical Trial Update: Analgesic Effect of an Injection of Botulinum Toxin Type A in the Ganglion Impar in Patients With Chronic Proctalgia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing analgesic effects of botulinum toxin type A injected into the ganglion impar for chronic proctalgia has completed. The study reports on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proctalgia

Drugs mentioned

• Botulinum toxin type A (OnabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: Nantes University Hospital | Conditions: Proctalgia | Phase 2 | Status: COMPLETED